Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Statements of Cash Flows

v3.22.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2022
Jan. 31, 2021
Jan. 31, 2020
Cash flow from operating activities:      
Net loss $ (111,470) $ (37,970) $ (39,754)
Net loss attributable to redeemable noncontrolling interests 0 0 (27)
Net loss (111,470) (37,970) (39,781)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization expense 8,058 5,690 4,416
Bad debt expense (186) 689 1,707
Stock-based compensation expense 50,131 43,883 10,166
Litigation settlement 12,000 0 0
Non-cash interest paid in kind and discount amortization 3,266 5,523 0
Deferred income taxes 235 110 (32)
Other non-cash items, net (1,272) (712) (423)
Changes in operating assets and liabilities:      
Accounts receivable (47,094) (9,781) (11,553)
Prepaid expenses and other current assets (8,220) (28,709) (22,347)
Other non-current assets (6,764) (7,082) (9,881)
Accounts payable (1,095) 6,077 (10,185)
Accrued expenses and other current liabilities 25,510 12,286 6,977
Deferred revenue 43,404 17,511 88,866
Other liabilities 575 (204) 1,036
Net cash (used in) provided by operating activities (32,922) 7,311 18,966
Cash flow from Investing activities:      
Purchases of marketable securities (267,826) (212,973) 0
Sales of marketable securities 56,652 0 0
Maturities of marketable securities 211,555 0 0
Purchases of property and equipment (6,148) (2,701) (2,633)
Capitalized internal-use software (6,258) (3,783) (2,533)
Acquisitions, net of cash acquired (3,625) 0 (6,500)
Net cash used in investing activities (15,650) (219,457) (11,666)
Cash flow from financing activities:      
Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts, commissions and other offering costs 275,973 0 0
Proceeds from issuance of convertible preferred stock, net of issuance costs 0 191,752 0
Proceeds from Senior subordinated secured convertible notes 0 73,425 0
Proceeds from issuance of stock warrants 0 7,639 0
Repurchase of preferred stock 0 (12,416) 0
Deemed dividend on preferred stock 0 (600) 0
Proceeds from short-term borrowings 0 49,973 31,500
Repayments of short term borrowings 0 (49,973) (41,000)
Payments of debt and equity issuance costs 0 (475) 0
Repurchase of common stock 0 (5,874) 0
Proceeds from issuance of common stock upon exercise of stock options 20,054 16,333 1,971
Proceeds from issuance of common stock upon ESPP purchase 7,105 0 0
Net cash provided by (used in) financing activities 303,132 269,784 (7,529)
Effect of exchange rate fluctuations on cash and cash equivalents (1,171) (71) (173)
Net change in cash and cash equivalents 253,389 57,567 (402)
Cash and cash equivalents at beginning of period 68,037 10,470 10,872
Cash and cash equivalents at end of period 321,426 68,037 10,470
Supplemental disclosure of cash flow information      
Cash paid for income taxes 3,458 3,187 2,733
Cash paid for interest 0 224 547
Supplemental disclosure for non-cash investing and financing      
Accrued purchases of property and equipment 216 382 260
Stock-based compensation expense capitalized in internal-use software 696 0 0
Common stock issued 0 0 7,181
Accrued for asset retirement obligations 0 476 962
Stock Issued, Noncash Assets      
Supplemental disclosure for non-cash investing and financing      
Common stock issued $ 0 $ 5,000 $ 0